Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center published promising findings today in the New England Journal of Medicine on preventing a common complication to lifesaving blood stem cell transplantation in leukemia.
Alexander G. Robling, PhD, a professor, researcher and leader at Indiana University School of Medicine has been selected to chair the school’s Department of Anatomy, Cell Biology and Physiology. His new appointment beings January 1, 2021.
An Indiana University Melvin and Bren Simon Comprehensive Cancer Center researcher has been awarded a five-year, $2.9 million grant from the National Cancer Institute to develop a drug that could make radiation therapy far more effective.
Indiana University School of Medicine has announced a New York-based physician leader has been named the new chair of the Department of Anesthesia. David C. Adams, MD, will assume the role of department chair effective January 1, 2021 and will have oversight and responsibility for the program’s clinical, education and research programs.
D. Wade Clapp, MD, chair of the Department of Pediatrics at Indiana University School of Medicine, has been elected to the National Academy of Medicine (NAM). The group announced the election of 100 new members during its annual meeting on Monday, October 19, 2020. Election to the academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
Indiana University School of Medicine has announced the hiring of a world-recognized medical oncologist and multiple myeloma researcher to lead the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, bolstered by a $15 million fund established by the Walther Cancer Foundation to support him in this role.
Indiana University School of Medicine has named Laurie Gutmann, MD, the new chair for the Department of Neurology. Gutmann also will serve as co-director of the Neuroscience Institute, an umbrella entity designed to facilitate collaboration among neuroscience disciplines at IU School of Medicine and IU Health.
Mark R. Kelley, PhD, is the newest member of the IU Ventures Investment Committee. Kelley, a professor of pediatrics and cancer researcher at Indiana University School of Medicine, was appointed by Jay L. Hess, MD, PhD, MHSA, dean of IU School of Medicine and IU Ventures board member. Kelley succeeds Distinguished Professor Emeritus Mervin Yoder, MD, who served on the committee from 2014 to 2020.